TEPMETKO® (tepotinib) BRIDGE PROGRAM

CoverOne offers a Bridge program to assist eligible patients to obtain their initial prescription of TEPMETKO® (tepotinib) free of charge, if the following criteria are met.

The patient must:

  • Be a new patient with a prescription for TEPMETKO
  • Be diagnosed by their physician with the FDA approved indication of TEPMETKO.
  • Be insured (i.e., a commercial insurer or a federal health care program)
  • Have experienced a delay in a coverage determination of at least 5 business days

Please fax a completed CoverOne TEPMETKO Enrollment Form to verify benefits or request assistance.

NOTE: Bridge program is only applicable for TEPMETKO.